Conference call scheduled for 4:30 p.m. ET today Initiation of Phase 3 Studies for Subcutaneous VK2735 for Obesity Planned for 2Q25 Phase 2 VENTURE-Oral Dosing Trial ...

A City Council debate over whether a controversial pro-Gaza puppet display at the Chicago Cultural Center is antisemitic or a fair expression of free speech descended into disorder Tuesday, with an ...

Background: The COVID-19 pandemic period was associated with increased alcohol consumption. We sought to estimate excess ...

Imprisoned former Ald. Edward Burke has become the latest Chicago Democrat to seek clemency from someone who, at first blush, would seem like an unlikely suitor: Republican President ...

A lawyer for former House Speaker Michael Madigan is scheduled to continue his final pitch to the jury Monday by attacking allegations of a ComEd bribery scheme as ...

The five-bedroom, 3,283-square-foot bungalow in Oak Park that onetime Chicago Outfit chief Sam Giancana owned — and the home in whose basement Giancana was slain in a 1975 crime that never has been ...

Flood alerts remain in effect across portions of the Los Angeles area in Southern California as much-needed rain moves into ...

Cady says the Oxford PE-ALD machine is a step up for the Innovation ... federal government through the CHIPS and Science Act, a $52 billion fund passed by Congress in 2023 to help “reshore ...

Viking Therapeutics, Inc. offers promising advances in obesity and liver diseases, despite a recent stock drop over GLP-1 market concerns. Click for my VKTX update.

Investors are pressuring the Aussie energy provider on Thursday. But why? The post Why this $7 billion ASX 200 energy stock is falling hard today appeared first on The Motley Fool Australia.

The Dax was down -0.75% before the S&P futures cash open at 8:30 CT. On Tuesday the futures sold off and followed through on the overnight Globex session and then tumbled lower in the early part ...